The forecast for healthcare expenditure on prescribed medicines in Norway from 2024 to 2028 shows a gradual decline. In 2023, the expenditure stood at 387.42 Euros per capita. In 2024, it is expected to be 382.97 Euros per capita, reflecting a year-on-year decrease of 1.16%. From 2025 to 2028, the expenditure decreases further, with a 1.1% drop in 2025 to 378.77 Euros, a 1.06% drop in 2026 to 374.59 Euros, a 1.11% drop in 2027 to 370.44 Euros, and a 1.09% drop in 2028 to 366.3 Euros. The compound annual growth rate (CAGR) over the 5-year period indicates an average annual decrease of approximately 1.08%.
Future trends to watch for include the impact of healthcare policy changes, the launch of biosimilars, advancements in personalized medicine, and cost-containment measures by the government. Additionally, the aging population and innovation in pharmaceutical technology could influence both the volume and value of prescribed medicines expenditure.
